Global, regional, and country-level cost of leptospirosis due to loss of productivity in humans.
Suneth Buddhika AgampodiSajaan GunarathnaJung-Seok LeeJean-Louis ExclerPublished in: PLoS neglected tropical diseases (2023)
Although significant, the cost estimate due to loss of productivity is merely a fraction of the overall economic burden of this disease, which also includes other direct, indirect, and intangible costs. The existing partial estimates of the different components of economic cost suggest a profound economic burden that demands the inclusion of leptospirosis in the global health agenda for comprehensive disease control and prevention efforts, including vaccine development.